US Lawmakers Pass Bill to Restrict Biotechnology Firms with Ties to China
Technology tamfitronics WASHINGTON DC, USA — A California-based biotechnology company specialising in genetic testing is among the businesses that could be barred from working in the U.S. market due to their ties to China, signaling a growing conflict between health innovation and a bipartisan effort in the US Congress to curtail Beijing’s global influence.Complete Genomics, which helps doctors detect genetic causes for cancer, is facing exclusion after the U.S. House passed the BIOSECURE Act this week. The act prevents federal funds from benefiting Chinese-linked firms, including Complete Genomics and four other companies. The legislation, which passed with a 306-81 vote, is part of a broader legislative package aimed at countering China’s influence, particularly in technology sectors.Radoje Drmanac, Complete Genomics’ founder and chief scientific officer, voiced frustration over the bill’s impact.“It’s just a loss for the...